(Q73676348)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The pattern of serum markers in patients with androgen-independent adenocarcinoma of the prostate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Kim J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Palmer JL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Finn L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hodges S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Bowes V V

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Deftos L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Murphy G

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Logothetis C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

97-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

An evaluation of prostate specific antigen in prostatic cancer

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate-specific antigen and prostate gland volume: Correlation and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Interleukin-6: a candidate mediator of human prostate cancer morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Evidence for the existence of an organ specific, androgen-independent pathway of progression in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Secretion of chromogranin A by peptide-producing endocrine neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2899%2900047-2

7 January 2021

10.1016/S1078-1439(99)00047-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765015%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference